TY  - JOUR
AU  - Sciascia, S
AU  - Coloma-Bazan, E
AU  - Radin, M
AU  - Bertolaccini, M L
AU  - Lopez-Pedrera, C
AU  - Espinosa, Gerard
AU  - Meroni, P L
AU  - Cervera, R
AU  - Cuadrado, M J
PY  - 2017
DO  - 10.1016/j.autrev.2017.09.004
UR  - http://hdl.handle.net/10668/11574
T2  - Autoimmunity reviews
AB  - The current mainstay of treatment in patients with thrombotic antiphospholipid syndrome (APS) is long-term anticoagulation, mainly with Vitamin K antagonist agents. Some recently available studies have created new ground for discussion about the...
LA  - en
PB  - Elsevier
KW  - Anticoagulation
KW  - Antiphospholipid antibodies
KW  - Antiphosphospholipid syndrome
KW  - Thrombosis
KW  - Antibodies, antiphospholipid
KW  - Anticoagulants
KW  - Antiphospholipid syndrome
KW  - Humans
KW  - Prognosis
KW  - Risk factors
KW  - Seroconversion
KW  - Thrombosis
TI  - Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion?
TY  - research article
VL  - 16
ER  -